CliffBio
small molecule

HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE

HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Active ingredientHYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
Strength5MG/5ML;60MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2014
Marketing statusDISCN

More from Tris.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio